“No monthly/yearly membership needed” is a meaningful part of Medi-Slim Weight Loss’s offer, but it is not a complete treatment agreement. For someone considering this Las Vegas clinic, the central contract question is what replaces that membership: which services the treatment payment buys, when another payment becomes due, and what happens if care changes or stops. The public documentation gives a useful outline of a medically supervised program without establishing all of those financial boundaries.
Medi-Slim advertises semaglutide, tirzepatide and phentermine, with its most detailed package description devoted to semaglutide. This review examines the clinic’s public pages consulted October 19, 2026, focusing on enrollment promises, included services and responsibility gaps rather than predicted weight loss. The clinic documents a physical location, appointment channels and ongoing monitoring. It does not identify the specific GLP-1 products dispensed, the dispensing pharmacy, or complete billing, cancellation and refund terms. Those omissions are questions to resolve—not proof that the clinic lacks workable policies.
At a glance
- Semaglutide price
- The medically supervised semaglutide program starts at $199 per month; this is not a universal final price.Sources: [3]
- Tirzepatide promotion
- Tirzepatide starts at $299 in a limited-time offer, but the advertised text does not specify the billing or supply period.Sources: [8]
- Membership language
- Medi-Slim says no monthly or yearly membership is needed. That does not establish whether treatment payments recur.Sources: [3]
- Documented package
- The semaglutide list includes consultation, physical examination, medication, B12, a vitamin supplement, meal planning and routine monitoring; the homepage also advertises labs.
Start with the promise, not the membership label
Medi-Slim presents itself as a medical weight-loss clinic in Las Vegas, not simply a medication subscription website. It says it has served Las Vegas and the surrounding area for more than 20 years. That is the provider’s account of its history and geographic focus; it does not establish nationwide availability. Its published street address gives prospective patients a concrete place to contact, while the public brand alone does not establish a separate legal entity name.
The clinic’s semaglutide page pairs “NO HIDDEN FEES” with “NO MONTHLY/YEARLY MEMBERSHIP NEEDED” and “JUST ONE LOW COST.” Those phrases describe the advertised commercial structure, but do not state a minimum commitment, renewal rule or payment authorization. A treatment program can have recurring medication or care charges without a separate membership fee. Conversely, the documentation does not establish that Medi-Slim automatically renews anything. Neither conclusion should be read into the slogan.
Before paying, request the agreement that actually governs treatment, including the name of the business collecting payment and the services it undertakes to provide. The website’s terms warn that online information should not substitute for individualized professional advice. That disclaimer does not answer enrollment questions. Our guide to terms to review before enrollment provides a useful framework for separating website advertising from the written obligations attached to a particular purchase.
The two advertised prices have different boundaries
The dedicated semaglutide page advertises a medically supervised program “Starting at just $199/month.” Both qualifications matter: $199 is a starting amount, and the stated period is a month. The documentation does not say that every treatment level costs that amount, identify an introductory-to-renewal price schedule, or establish a price lock. Nor does it define the monthly medication quantity. A monthly price should not be converted into a four-week supply or a guaranteed recurring charge without further terms.
The general presentation separately advertises semaglutide starting at $199 and tirzepatide starting at $299, followed by “Limited-time offer!!!” Unlike the dedicated semaglutide wording, that tirzepatide listing supplies no period. Calling it $299 per month would add a condition the clinic has not documented. Phentermine is described as having a low monthly cost, but no numerical price is given. The promotion’s expiration date and qualifications are also not established in the consulted pages.
A useful written quote would identify the selected medication, the first payment, the period it covers, subsequent charges and what could change the amount. It should also clarify whether payment is collected before the consultation, prescription decision or medication order. Insurance acceptance, insurance billing, prior authorization assistance and self-pay requirements are not documented here. These are separate questions: an advertised starting price does not by itself establish either insurance coverage or an obligation to pay privately.
| Offer or term | Documented statement | Clarification needed |
|---|---|---|
| Semaglutide | Medically supervised program starting at $199/month | Your final price, covered quantity and later charges |
| Tirzepatide | Starting at $299 in a limited-time offer | Billing period, supply period and offer qualifications |
| Phentermine | Low monthly cost; no dollar amount stated | Actual price and included services |
| Membership | No monthly/yearly membership needed | Whether medication or care payments recur |
| Laboratory work | Homepage advertises labs included | Named tests, frequency and any separately charged work |
Make the included-services list part of the agreement
Medi-Slim’s semaglutide package is more specific about services than many of its payment terms. The list includes a consultation, physical examination, semaglutide medication, vitamin B12, its “Super Energy Supplement Vitamin,” comprehensive meal plans with a grocery list, and routine monitoring, including body composition. These are documented program inclusions, not independently verified services received. Their practical value depends on what is provided at enrollment, what repeats, and what the patient must arrange separately.
Laboratory work needs particular clarification. The homepage describes an all-inclusive program with consultations, labs and supplements, while the detailed semaglutide inclusion list does not expressly enumerate labs. That difference is not proof that laboratory testing is excluded. It does mean the public pages do not provide a unified specification. Ask which tests are covered, whether collection and outside laboratory charges are included, and what happens financially if additional or repeat testing is requested.
The broader personalized weight-loss program may include diet education, plant-based supplements, appetite-suppressant medication, B12 and Lipo-B injections, nutritional counseling, health coaching and physician support. “May include” is not the same promise as an item expressly included in the semaglutide package. The clinic also says prescribed supplements and medicines are individualized. A written GLP-1 quote should distinguish the core purchase from optional additions, rather than treating every service mentioned anywhere on the website as included.
Enrollment describes an assessment, not a guaranteed prescription
The clinic describes a comprehensive assessment and consultation during which its team considers treatment combinations and personalizes a program. It lists semaglutide, tirzepatide and phentermine among prescription options, alongside supplements. That is evidence of the services it markets, not a promise that every applicant will receive a particular prescription. The public documentation does not explain what a prospective patient owes if the assessment does not lead to medication or if the recommended option differs from the advertised one.
Medi-Slim describes physician-led care with ongoing medical oversight. Its team description names a doctor whom it characterizes as board-certified in obesity and bariatric-trained, a pharmacist, nurse practitioners and medical assistants. Those are provider statements, not independently verified credentials. They also do not establish who conducts each consultation or signs each prescription. Ask which professional handles the initial assessment, who is responsible for follow-up, and whether changing clinicians alters the service or fee.
The semaglutide page discusses BMI thresholds of 30 or higher, or 27 or higher with a weight-related condition, but does not present a complete clinic admission protocol. The consulted documentation leaves minimum age, exclusions and required preliminary testing unresolved. NIDDK likewise explains that medication decisions involve health conditions, other medicines, side effects and costs—not BMI alone. From a contract perspective, the useful question is when eligibility is assessed relative to payment, and what financial terms apply if treatment is not offered.
The medication and pharmacy responsibilities remain unspecified
The semaglutide page describes administration under the skin, but does not identify a brand, manufacturer or exact presentation. The consulted pages likewise do not establish which tirzepatide product is dispensed or whether either medicine is an approved commercial product or a compounded preparation. This is a material purchase detail, not a minor naming issue. The generic ingredient name and a starting price are insufficient to identify exactly what a patient would receive.
The clinic’s use of FDA-approval language should therefore be read narrowly. FDA approval attaches to a specific product, not to a clinic or automatically to every preparation containing a named ingredient. FDA says compounded preparations are not approved and do not undergo its premarket review for safety, effectiveness and quality; nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
No dispensing or compounding pharmacy is named in the consulted documentation. Having a pharmacist on the described team does not resolve that responsibility. Nor are pickup, shipping fees, dispatch times or arrival expectations established. A privacy-policy reference to arranging deliveries is not confirmation of medication shipping. Use a map of provider responsibilities to ask who handles prescription transmission, dispensing and delivery problems. If an injectable arrives warm or inadequately refrigerated, FDA advises not using it and contacting the provider or pharmacy.
Ongoing monitoring needs an operational definition
Medi-Slim says its program is continuously monitored and that its general weight-loss service tracks progress with a body-composition scale. The semaglutide package also expressly includes routine monitoring. These statements support an expectation of follow-up, but do not specify appointment intervals, clinician review times or how patients report concerns between visits. Body-composition tracking describes one monitoring tool; it does not by itself define the full clinical follow-up service or establish how often it is available.
For existing patients, the website specifically instructs them to call the office for their next visit. That is a concrete continuity-of-care step worth noting before assuming repeat appointments happen automatically. New consultations can be requested by phone or through online booking. The clinic says it is open Tuesday through Saturday; its detailed Tuesday–Friday hours are 9 a.m. to 5 p.m., with a lunch closure from 1 to 2 p.m. Confirm Saturday availability directly.
The local service description does not establish telemedicine availability or treatment outside Las Vegas and its surroundings. For someone arranging travel or recurring visits, ask which appointments require attendance, whether any remote follow-up is offered, and what happens if a visit is missed or delayed. The documentation does not specify missed-appointment charges or support response deadlines. NIDDK describes follow-up as addressing treatment tolerance and response; a billing schedule alone would not explain how those care responsibilities are met.
Stopping treatment and recovering money are separate questions
The consulted pages do not establish automatic renewal terms, a minimum purchase commitment, treatment-cancellation procedures or refund rules. That absence does not prove that Medi-Slim imposes a long contract, and it does not prove that patients can leave without financial consequences. The correct conclusion is narrower: public documentation does not settle the issue. Ask for the applicable policy before payment, including whether medication, consultations and optional services have different cancellation boundaries.
Several possible events deserve separate answers: canceling an appointment, declining a recommended prescription, stopping future treatment payments and requesting money back for a purchase already made. None should be assumed to accomplish the others. Request the required notice method, any deadline, and the point after which a medication order or completed service becomes nonrefundable. Our guide to cancellation notice and order status explains why dates and transaction stages matter even when no membership fee is charged.
The promotion adds another unresolved issue: what happens after the limited-time offer ends. The pages do not provide a subsequent-price schedule or promise that a booking preserves a promotional rate. Ask how changes are communicated and whether you can decline the next purchase before being charged. Treatment duration is also a clinical question; NIDDK notes that it depends on response and side effects and may be long term. That does not establish Medi-Slim’s contract duration or justify assuming an ongoing payment commitment.
Use the contact channels without confusing their purposes
Medi-Slim publishes 725-977-0665 for appointments and 702-258-8456 for general inquiries. It also offers a contact form for questions, concerns and comments. These give prospective patients practical routes to request prices and policies, but the documentation does not establish a dedicated billing-resolution team, secure patient portal or guaranteed response time. A sensible first call is to ask which channel can provide the treatment agreement and which channel handles confidential clinical questions.
The contact form carries an unusually important limitation: submissions are forwarded by email, not through a secure messaging system, and the form should not be used to transmit private health information. That warning should govern how readers use it. A general question about receiving the cancellation policy is different from submitting a medical history or laboratory results. The privacy policy also permits data sharing with trusted partners for functions including analysis, correspondence, support and arranging deliveries.
SMS alerts are voluntary and cover appointments and care. The site says frequency varies, message and data rates may apply, and recipients can reply STOP to opt out. That opt-out controls text communications; it is not documented as a treatment-cancellation mechanism. Before enrollment, distinguish permission to contact you from authorization to charge you and from consent to care. Written answers on those separate issues would make the clinic’s otherwise useful service descriptions substantially more actionable.
Questions & answers
Is Medi-Slim’s semaglutide program guaranteed to cost $199 per month?
No. Its wording is “starting at” $199 per month for the medically supervised semaglutide program. The pages do not establish a universal final charge, a medication quantity or a later-price schedule. Request a quote for the proposed treatment that identifies included services, the covered period and circumstances that could change the price. The separate no-membership claim does not fill in those details.
Does the $299 tirzepatide offer cover a month?
The consulted advertising does not say. It lists tirzepatide starting at $299 as part of a limited-time offer without specifying a billing or supply period. Do not assume it follows the monthly wording on the semaglutide page. Ask what the $299 purchases, who qualifies for that amount, when the promotion expires and what a subsequent purchase would cost.
Are labs and follow-up included in the semaglutide package?
Routine monitoring is expressly listed on the semaglutide page, including body composition. The homepage additionally advertises labs, consultations and supplements as included. The pages do not identify the tests or monitoring frequency, and the detailed package list does not expressly name labs. Ask for a single written inclusion list specifying testing, repeat testing, follow-up visits and any outside charges.
Which pharmacy supplies Medi-Slim’s GLP-1 medicines?
The consulted public documentation does not identify a dispensing pharmacy or the exact semaglutide or tirzepatide products. A pharmacist is included in the clinic’s team description, but that does not establish the dispensing arrangement. Before purchasing, request the product name, formulation, presentation and pharmacy identity, along with whether medication is collected locally or delivered and who handles fulfillment concerns.
Can I cancel whenever I want and receive a refund?
The public pages do not establish either right. No monthly or yearly membership is required according to the advertising, but treatment-cancellation rules, notice requirements and refund boundaries remain undocumented here. Ask separately how to stop future purchases and whether an existing payment is refundable. Opting out of appointment texts with STOP should not be treated as canceling treatment or requesting a refund.
How should an existing patient arrange another visit or send medical information?
The website instructs existing patients to call the office for their next visit and lists 725-977-0665 for appointments. It does not establish a secure clinical messaging channel. Its general contact form specifically warns against sending private health information because submissions are forwarded by email. Call to ask how to communicate confidential treatment information rather than putting it into that form.
Our assessment
Medi-Slim documents a recognizable local medical weight-loss service: a Las Vegas office, multiple prescription options, a detailed semaglutide inclusion list and ongoing monitoring. Its no-membership positioning and published starting prices are useful disclosures. They are not, however, a complete account of what a patient agrees to buy. The most consequential unresolved points are the exact medication and pharmacy, the period behind the tirzepatide offer, final and subsequent charges, and cancellation and refund boundaries. A prospective patient can use the advertised package as a starting specification, then request a written quote and applicable agreement before paying. Clear answers would strengthen the offer’s practical transparency; their absence from public pages should neither be overlooked nor treated as proof of misconduct.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Medi-Slim Weight Loss — services/semaglutide ↗
- Medi-Slim Weight Loss — contactus ↗
- Medi-Slim Weight Loss — your privacy ↗
- Medi-Slim Weight Loss — our terms ↗
- Medi-Slim Weight Loss — official website ↗
- Medi-Slim Weight Loss — about ↗
- Medi-Slim Weight Loss — services/weight loss ↗